摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(Z)-5-(1-(quinolin-6-yl)ethylidene)-2-thioxothiazolidin-4-one | 938047-08-6

中文名称
——
中文别名
——
英文名称
(Z)-5-(1-(quinolin-6-yl)ethylidene)-2-thioxothiazolidin-4-one
英文别名
——
(Z)-5-(1-(quinolin-6-yl)ethylidene)-2-thioxothiazolidin-4-one化学式
CAS
938047-08-6
化学式
C14H10N2OS2
mdl
——
分子量
286.378
InChiKey
BFVKQOGPYDGBSM-WQLSENKSSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.11
  • 重原子数:
    19.0
  • 可旋转键数:
    1.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    41.99
  • 氢给体数:
    1.0
  • 氢受体数:
    4.0

反应信息

  • 作为反应物:
    描述:
    (Z)-5-(1-(quinolin-6-yl)ethylidene)-2-thioxothiazolidin-4-oneN,N-二异丙基乙胺 作用下, 以 乙醇乙腈 为溶剂, 反应 12.33h, 生成 Sdccgrch-0000154.P001
    参考文献:
    名称:
    Synthesis and activity of quinolinyl-methylene-thiazolinones as potent and selective cyclin-dependent kinase 1 inhibitors
    摘要:
    A novel series of quinolinyl-methylene-thiazolinones has been identified as potent and selective cyclin-dependent kinase I (CDK1) inhibitors. Their synthesis and structure activity relationships (SAR) are described. Representative compounds from this class reversibly inhibit CDK1 activity in vitro, and block cell cycle progression in human tumor cell lines, suggesting a potential use as antitumor agents. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.01.081
  • 作为产物:
    描述:
    罗丹宁6-乙酰基喹啉 在 ammonium acetate 作用下, 以 甲苯 为溶剂, 反应 24.0h, 生成 (Z)-5-(1-(quinolin-6-yl)ethylidene)-2-thioxothiazolidin-4-one
    参考文献:
    名称:
    Synthesis and activity of quinolinyl-methylene-thiazolinones as potent and selective cyclin-dependent kinase 1 inhibitors
    摘要:
    A novel series of quinolinyl-methylene-thiazolinones has been identified as potent and selective cyclin-dependent kinase I (CDK1) inhibitors. Their synthesis and structure activity relationships (SAR) are described. Representative compounds from this class reversibly inhibit CDK1 activity in vitro, and block cell cycle progression in human tumor cell lines, suggesting a potential use as antitumor agents. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.01.081
点击查看最新优质反应信息